No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study
- 1 February 2002
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 123 (1-2) , 193-198
- https://doi.org/10.1016/s0165-5728(01)00493-3
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A CTLA‐4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidismClinical Endocrinology, 1997
- A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complexNature Genetics, 1996
- A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22Nature Genetics, 1996
- The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes RegistryHuman Molecular Genetics, 1996
- A genetic basis for familial aggregation in multiple sclerosisNature, 1995
- CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian populationJournal of Clinical Endocrinology & Metabolism, 1995
- Anti‐myelin basic protein and anti‐proteolipid protein specific forms of multiple sclerosisAnnals of Neurology, 1994
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- A Population-Based Study of Multiple Sclerosis in TwinsNew England Journal of Medicine, 1986